# Long-term Monitoring of Growth and Development of Pediatric Patients Previously Treated With Everolimus

> **NCT02338609** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 15 (actual)

## Conditions studied

- Growth and Development

## Interventions

- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT02338609
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-17
- **Primary completion:** 2023-12-18
- **Final completion:** 2023-12-18
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02338609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02338609, "Long-term Monitoring of Growth and Development of Pediatric Patients Previously Treated With Everolimus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02338609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*